GLP-1 receptor agonists that treat Type 2 diabetes are Semaglutide, Tirzepatide, and Dulaglutide which are all medications used to treat Type 2 Diabetes and obesity
Any cell with these receptors can respond to it
The effects, albeit in the bum, are similar to those who've battled 'Ozempic face' with the rapid weight loss leaving some users looking ill, exacerbating wrinkles and causing skin to sag
Further studies are needed to confirm the actual benefit of this molecule on metabolic liver diseases and define the best route of administration and the most appropriate dosage, allowing its use in clinical practice
CalabresiPCastriotoADi FilippoMPicconiB
Together, these therapies form a comprehensive pharmacologic toolbox that can be tailored to each patients needs